Cell Source Inc CLCS:Over The Counter Mkt

*Data is delayed | Exchange | USD
Last | 04/16/24 EDT
0.398UNCH (UNCH)
52 week range
0.00 - 0.74
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.398
  • 52 Week High0.74
  • 52 Week High Date09/26/23
  • 52 Week Low0.00
  • 52 Week Low Date05/11/23

Key Stats

  • Market Cap15.341M
  • Shares Out38.55M
  • 10 Day Average Volume7,280
  • Dividend-
  • Dividend Yield-
  • Beta-9.09
  • YTD % Change-13.48

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.398
  • 52 Week High0.74
  • 52 Week High Date09/26/23
  • 52 Week Low0.00
  • 52 Week Low Date05/11/23
  • Market Cap15.341M
  • Shares Out38.55M
  • 10 Day Average Volume7,280
  • Dividend-
  • Dividend Yield-
  • Beta-9.09
  • YTD % Change-13.48

RATIOS/PROFITABILITY

  • EPS (TTM)-0.18
  • P/E (TTM)-2.20
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-4.389M
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-13.47%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Cell Source Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Cell Source, Inc. is a cell therapy company focused on immunotherapy. The Company is primarily focused on the development of immune system management technology (Veto Cell technology). Its lead prospective product is its Veto Cell immune system management technology. Its Veto Cell technology is an immune tolerance biotechnology that enables the selective blocking of immune responses. Its Veto Cell technology is in pre-clinical phase, and its data shows that it provides...
Dennis Brown Ph.D.
Independent Chairman of the Board
Itamar Shimrat
Chief Executive Officer, Chief Financial Officer, Director
Address
57 West 57Th Street, Suite 400
New York, NY
10019
United States